GE, Biosense Webster to develop interventional ultrasound for electrophysiology
GE Healthcare has expanded its strategic alliance with Biosense Webster, a Johnson & Johnson company, to develop real-time ultrasound imaging for use in electrophysiology procedures.
manager of GE’s interventional cardiovascular ultrasound business. “In this new development, we are integrating GE’s capabilities in high performance ultrasound imaging with the leading EP catheter technologies from Biosense Webster. Together, we will create new imaging solutions for intracardiac therapies, augmenting current technologies with new real-time visualization of the cardiac anatomy and therapy catheters.”

The Diamond Bar, Calif.-based Biosense Webster is a developer of technologies behind the diagnosis and treatment of cardiac arrhythmias.